Cargando…
Digital Health Technology to Measure Drug Efficacy in Clinical Trials for Parkinson’s Disease: A Regulatory Perspective
Digital health technology (DHT), including wearable and environmental sensors, video cameras and other electronic tools, has provided new opportunities for the measurement of movement and functionality in Parkinson’s disease. Compared to current standards for evaluation of the disease (MDS-UPDRS), D...
Autores principales: | Sacks, Leonard, Kunkoski, Elizabeth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8385502/ https://www.ncbi.nlm.nih.gov/pubmed/33459666 http://dx.doi.org/10.3233/JPD-202416 |
Ejemplares similares
-
Evolving regulatory perspectives on digital health technologies for medicinal product development
por: Colloud, Seya, et al.
Publicado: (2023) -
Metadata Framework to Support Deployment of Digital Health Technologies in Clinical Trials in Parkinson’s Disease
por: Hill, Derek L., et al.
Publicado: (2022) -
Digital health technology in clinical trials
por: Mittermaier, Mirja, et al.
Publicado: (2023) -
Impact of digital technologies on self-efficacy in people with Parkinson’s: a scoping review protocol
por: Hall, Andrew Michael, et al.
Publicado: (2023) -
Crowdsourcing digital health measures to predict Parkinson’s disease severity: the Parkinson’s Disease Digital Biomarker DREAM Challenge
por: Sieberts, Solveig K., et al.
Publicado: (2021)